Clinical Trial Update: QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial QUILT-3.031 evaluating AMG 337 in advanced or metastatic clear cell sarcoma was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Sarcoma

Drugs mentioned

• AMG 337

Snippet

Sponsor: NantPharma, LLC | Conditions: Clear Cell Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2024-05-24